de Jong N, Klungel OH, Verhagen H: Functional foods: the case for closer evaluation. BMJ. 2007, 334 (7602): 1037-1039. 10.1136/bmj.39196.666377.BE.
Article
PubMed
PubMed Central
Google Scholar
Talley NJ, Gabriel SE, Harmsen WS: Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995, 109 (6): 1736-1741. 10.1016/0016-5085(95)90738-6.
Article
CAS
PubMed
Google Scholar
Kennedy TM, Jones RH, Hungin AP: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut. 1998, 43 (6): 770-774. 10.1136/gut.43.6.770.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thompson WG, Heaton KW, Smyth GT: Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 2000, 46 (1): 78-82. 10.1136/gut.46.1.78.
Article
CAS
PubMed
PubMed Central
Google Scholar
Agreus L, Svardsudd K, Nyren O: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995, 109 (3): 671-680. 10.1016/0016-5085(95)90373-9.
Article
CAS
PubMed
Google Scholar
Wilson S, Roberts L, Roalfe A: Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract. 2004, 54 (504): 495-502.
PubMed
PubMed Central
Google Scholar
Drossman DA, Li Z, Andruzzi E: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993, 38 (9): 1569-1580. 10.1007/BF01303162.
Article
CAS
PubMed
Google Scholar
Hungin AP, Whorwell PJ, Tack J: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003, 17 (5): 643-650. 10.1046/j.1365-2036.2003.01456.x.
Article
CAS
PubMed
Google Scholar
Jones R, Lydeard S: Irritable bowel syndrome in the general population. BMJ. 1992, 304 (6819): 87-90. 10.1136/bmj.304.6819.87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Posserud I, Ersryd A, Simren M: Functional findings in irritable bowel syndrome. World J Gastroenterol. 2006, 12 (18): 2830-2838.
Article
PubMed
PubMed Central
Google Scholar
O'Keefe EA, Talley NJ, Zinsmeister AR: Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995, 50 (4): M184-M189.
Article
PubMed
Google Scholar
Farndale R, Roberts LM: Long-term impact of irritable bowel syndrome: a qualitative study. Primary Health Care Research & Development. 2011, 12: 52-67. 10.1017/S1463423610000095.
Article
Google Scholar
Harris LR, Roberts L: Treatments for irritable bowel syndrome: patients' attitudes and acceptability. BMC Complement Altern Med. 2008, 8: 65-10.1186/1472-6882-8-65.
Article
PubMed
PubMed Central
Google Scholar
Leatherhead Food International: The international market for functional foods. Market report leaflet. 2006, :
Google Scholar
Salonen A, de Vos WM, Palva A: Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology. 2010, 156: 3205-3215. 10.1099/mic.0.043257-0.
Article
CAS
PubMed
Google Scholar
Quigley EM: Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am. 2011, 40: 207-222. 10.1016/j.gtc.2010.12.009.
Article
PubMed
Google Scholar
Moayyedi P, Ford AC, Talley NJ: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010, 59: 325-332. 10.1136/gut.2008.167270.
Article
CAS
PubMed
Google Scholar
Hoveyda N, Heneghan C, Mahatani KR: A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009, 9: 15-10.1186/1471-230X-9-15.
Article
PubMed
PubMed Central
Google Scholar
Montrose DC, Floch MH: Probiotics used in human studies. J Clin Gastroenterol. 2005, 39 (6): 469-484. 10.1097/01.mcg.0000165649.32371.71.
Article
PubMed
Google Scholar
Floch MH: Use of diet and probiotic therapy in the irritable bowel syndrome: analysis of the literature. J Clin Gastroenterol. 2005, 39 (5 Suppl): S243-S246.
Article
PubMed
Google Scholar
Krammer HJ, Schlieger F, Harder H: Probiotics as therapeutic agents in irritable bowel syndrome. Z Gastroenterol. 2005, 43 (5): 467-471. 10.1055/s-2004-813934.
Article
PubMed
Google Scholar
Young P, Cash BD: Probiotic use in irritable bowel syndrome. Curr Gastroenterol Rep. 2006, 8 (4): 321-326. 10.1007/s11894-006-0053-1.
Article
PubMed
Google Scholar
Guyonnet D, Schlumberger A, Mhamdi L: Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms. A randomised, double-blind, parallel, controlled study. Br J Nut. 2009, 102: 1654-1662. 10.1017/S0007114509990882.
Article
CAS
Google Scholar
Agrawal A, Houghton LA, Morris J: Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2009, 29: 104-114. 10.1111/j.1365-2036.2008.03853.x.
Article
CAS
PubMed
Google Scholar
Guyonnet D, Chassany O, Ducrotté P: Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 2007, 26: 475-486. 10.1111/j.1365-2036.2007.03362.x.
Article
CAS
PubMed
Google Scholar
Marteau P, Cuillerier E, Meance S: Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther. 2002, 16 (3): 587-593. 10.1046/j.1365-2036.2002.01188.x.
Article
CAS
PubMed
Google Scholar
Drossman DA, Corazziari E, Delvaux M: Rome III. The functional gastrointestinal disorders. 2006, Virginia, USA: Degnon Associates, 3
Google Scholar
Francis CY, Morris J, Whorwell PJ: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997, 11 (2): 395-402. 10.1046/j.1365-2036.1997.142318000.x.
Article
CAS
PubMed
Google Scholar
Irvine EJ, Whitehead WE, Chey WD: Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006, 130 (5): 1538-1551. 10.1053/j.gastro.2005.11.058.
Article
PubMed
Google Scholar
Mangel AW: Personal view: adequate relief as a primary endpoint in irritable bowel syndrome. Aliment Pharmacol Ther. 2006, 23 (7): 879-881. 10.1111/j.1365-2036.2006.02839.x.
Article
CAS
PubMed
Google Scholar
Roalfe A, Roberts L, Wilson S: Evaluation of an IBS-specific symptom questionnaire. BMC Gastroenterol. 2008, 8: 30-10.1186/1471-230X-8-30.
Article
PubMed
PubMed Central
Google Scholar
Patrick DL, Drossman DA, Frederick IO: Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998, 43 (2): 400-411. 10.1023/A:1018831127942.
Article
CAS
PubMed
Google Scholar
Whorwell PJ, Altringer L, Morel J: Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome. Am J Gstroenterol. 2006, 101: 1581-1590. 10.1111/j.1572-0241.2006.00734.x.
Article
Google Scholar
Méance S, Cayuela C, Turchet P: A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-fecal gut transit time in elderly. Microb Ecol Health Dis. 2001, 13: 217-222. 10.1080/089106001753341291.
Article
Google Scholar
Méance S, Cayuela C, Turchet P: Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microb Ecol Health Dis. 2003, 15: 15-22. 10.1080/08910600310015565.
Article
Google Scholar
Bouvier M, Méance S, Bouley C: Effects of consumption of a milk fermented by a probiotic Bifidobacterium animalis (strain DN-173 010) on colonic transit times in healthy humans. Bioscience Microflora. 2001, 20: 43-48.
Article
CAS
Google Scholar
Camilleri M: Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006, 40 (3): 264-269. 10.1097/00004836-200603000-00020.
Article
PubMed
Google Scholar
Faber SM: Are probiotics useful in irritable bowel syndrome?. J Clin Gastroenterol. 2003, 37 (1): 93-94. 10.1097/00004836-200307000-00029.
Article
PubMed
Google Scholar
Madden JA, Hunter JO: A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr. 2002, 88 (Suppl 1): S67-S72.
Article
CAS
PubMed
Google Scholar
Quigley EM, Flourie B: Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007, 19 (3): 166-172. 10.1111/j.1365-2982.2006.00879.x.
Article
CAS
PubMed
Google Scholar
Quigley EM: The use of probiotics in functional bowel disease. Gastroenterol Clin North Am. 2005, 34 (3): 533-545. 10.1016/j.gtc.2005.05.008.
Article
PubMed
Google Scholar